Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.

<h4>Objective</h4>A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women.<h4>Methods</h4>This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kathryn L Hopkins, Maya Jaffer, Khuthadzo E Hlongwane, Kennedy Otwombe, Janan Dietrich, Mireille Cheyip, Jacobus Olivier, Tanya Doherty, Glenda E Gray
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/56cc4c7a5b7b4f3f81ed20444514674a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56cc4c7a5b7b4f3f81ed20444514674a
record_format dspace
spelling oai:doaj.org-article:56cc4c7a5b7b4f3f81ed20444514674a2021-12-02T20:08:50ZAssessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.1932-620310.1371/journal.pone.0255124https://doaj.org/article/56cc4c7a5b7b4f3f81ed20444514674a2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255124https://doaj.org/toc/1932-6203<h4>Objective</h4>A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women.<h4>Methods</h4>This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array HPV test and Pap smear liquid based cytology) and history of screening (known HIV status, antiretroviral therapy [ART] use, previous Pap smears). Data were stratified by age group (18-29, 30+ years), HIV status, Pap smear results and tested for statistical significance.<h4>Results</h4>Of 280 women, 20.4% were HIV-positive, 18.2% had abnormal Pap smears, 41.8% had HR-HPV. Of older women, 48.2% (n = 78/162) had never had a Pap smear. Of younger women, 89.0% (n = 105/118) never had a Pap smear, but had significantly more low-grade squamous intraepithelial lesions (LSIL) and other HR-HPV infection than older women (12.7%[n = 15/118] vs 4.9%[n = 8/162], p = 0.0193; and 49.2%[n = 58/118] vs 29.0%[n = 47/162], p = 0.0006; respectively). HIV-positive women had more abnormal cytology results and infection with other HR-HPV types or co-infection with other HR-HPV type(s)/HPV-16 compared to HIV-negative women (35.1%[n = 20/57] vs 13.9%[n = 31/223], p = 0.0002; 56.1%[n = 32/57] vs 32.7%[n = 73/223], p = 0.001; and 12.3%[n = 7/57] vs 4.9%[n = 11/223], p = 0.044; respectively). Of 57 HIV-positive women, 45.6% (n = 26) already knew their HIV status; of which 69.2% were on ART and 34.6% never had a Pap smear.<h4>Conclusion</h4>South African women have high rates of HIV, Pap smear abnormalities and HR-HPV, with low cervical cancer screening coverage. SA cervical cancer screening policy excludes (undiagnosed) HIV-positive and HIV-negative women <30 years, both populations found to have high prevalence of HR-HPV. HPV-based primary screening from 25 years could improve outcomes.Kathryn L HopkinsMaya JafferKhuthadzo E HlongwaneKennedy OtwombeJanan DietrichMireille CheyipJacobus OlivierTanya DohertyGlenda E GrayPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0255124 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kathryn L Hopkins
Maya Jaffer
Khuthadzo E Hlongwane
Kennedy Otwombe
Janan Dietrich
Mireille Cheyip
Jacobus Olivier
Tanya Doherty
Glenda E Gray
Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
description <h4>Objective</h4>A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women.<h4>Methods</h4>This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array HPV test and Pap smear liquid based cytology) and history of screening (known HIV status, antiretroviral therapy [ART] use, previous Pap smears). Data were stratified by age group (18-29, 30+ years), HIV status, Pap smear results and tested for statistical significance.<h4>Results</h4>Of 280 women, 20.4% were HIV-positive, 18.2% had abnormal Pap smears, 41.8% had HR-HPV. Of older women, 48.2% (n = 78/162) had never had a Pap smear. Of younger women, 89.0% (n = 105/118) never had a Pap smear, but had significantly more low-grade squamous intraepithelial lesions (LSIL) and other HR-HPV infection than older women (12.7%[n = 15/118] vs 4.9%[n = 8/162], p = 0.0193; and 49.2%[n = 58/118] vs 29.0%[n = 47/162], p = 0.0006; respectively). HIV-positive women had more abnormal cytology results and infection with other HR-HPV types or co-infection with other HR-HPV type(s)/HPV-16 compared to HIV-negative women (35.1%[n = 20/57] vs 13.9%[n = 31/223], p = 0.0002; 56.1%[n = 32/57] vs 32.7%[n = 73/223], p = 0.001; and 12.3%[n = 7/57] vs 4.9%[n = 11/223], p = 0.044; respectively). Of 57 HIV-positive women, 45.6% (n = 26) already knew their HIV status; of which 69.2% were on ART and 34.6% never had a Pap smear.<h4>Conclusion</h4>South African women have high rates of HIV, Pap smear abnormalities and HR-HPV, with low cervical cancer screening coverage. SA cervical cancer screening policy excludes (undiagnosed) HIV-positive and HIV-negative women <30 years, both populations found to have high prevalence of HR-HPV. HPV-based primary screening from 25 years could improve outcomes.
format article
author Kathryn L Hopkins
Maya Jaffer
Khuthadzo E Hlongwane
Kennedy Otwombe
Janan Dietrich
Mireille Cheyip
Jacobus Olivier
Tanya Doherty
Glenda E Gray
author_facet Kathryn L Hopkins
Maya Jaffer
Khuthadzo E Hlongwane
Kennedy Otwombe
Janan Dietrich
Mireille Cheyip
Jacobus Olivier
Tanya Doherty
Glenda E Gray
author_sort Kathryn L Hopkins
title Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
title_short Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
title_full Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
title_fullStr Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
title_full_unstemmed Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
title_sort assessing national cervical cancer screening guidelines: results from an hiv testing clinic also screening for cervical cancer and hpv in soweto, south africa.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/56cc4c7a5b7b4f3f81ed20444514674a
work_keys_str_mv AT kathrynlhopkins assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT mayajaffer assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT khuthadzoehlongwane assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT kennedyotwombe assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT janandietrich assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT mireillecheyip assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT jacobusolivier assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT tanyadoherty assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
AT glendaegray assessingnationalcervicalcancerscreeningguidelinesresultsfromanhivtestingclinicalsoscreeningforcervicalcancerandhpvinsowetosouthafrica
_version_ 1718375124972863488